
|Articles|July 1, 2004
Phase III study eyes intravitreal therapy for exudative AMD
Anti-VEGF monoclonal antibody fragment improves vision, reduce fluorescein angiographic leakage
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Anti-VEGF monoclonal antibody fragment improves vision, reduce fluorescein angiographic leakage